Copyright: ©Author(s) 2026.
World J Cardiol. Apr 26, 2026; 18(4): 117928
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.117928
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.117928
Table 4 The distribution of doses of guideline-directed medical therapy prescribed to the study population
| Drugs dose (mg/day) | mean ± SD | Median | Min | Max |
| Perindopril | 2.77 ± 1.01 | 2 | 2 | 4 |
| Ramipril | 2.86 ± 1.16 | 2.5 | 1.25 | 7.5 |
| Telmisartan | 36.97 ± 16.67 | 40 | 20 | 80 |
| Sacubitril valsartan | 88.89 ± 57.74 | 50 | 50 | 200 |
| Carvedilol | 6.4 ± 5.7 | 3.12 | 3.12 | 25 |
| Metoprolol | 50 ± 15.77 | 50 | 25 | 100 |
| Torsemide | 18.51 ± 4.08 | 20 | 5 | 50 |
| Spironolactone | 49.3 ± 4.14 | 50 | 25 | 50 |
| Furosemide | 17.69 ± 4.39 | 20 | 10 | 20 |
| Eplerenone | 25 ± 0 | 25 | 25 | 25 |
- Citation: Gailson L, Singh A, Pradhan A, Prajapathi S, Choudhary R, Bhandari M, Vishwakarma P, Shukla A, Sharma A, Chaudhary G, Chandra S, Sethi R, Dwivedi SK. Demographic and clinical profile of patients with heart failure at a tertiary care hospital. World J Cardiol 2026; 18(4): 117928
- URL: https://www.wjgnet.com/1949-8462/full/v18/i4/117928.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i4.117928